Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer?

N. Öcal (Ankara, Turkey), R. Ocal (Ankara, Turkey)

Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Session: Epidemiology, diagnosis and management of pulmonary embolism
Session type: E-poster session
Number: 3574
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Öcal (Ankara, Turkey), R. Ocal (Ankara, Turkey). Does platelet index examination provide clinical benefit in coexistence of pulmonary thromboembolism and cancer?. 3574

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Does d-dimer level predict pulmonary thromboembolism diagnosis in patients with lung cancer?
Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD
Year: 2019

Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course
Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases
Year: 2011

Evaluation of the medical knowledge degree about clinical suspicion of pulmonary thromboembolism (PTE)
Source: Eur Respir J 2006; 28: Suppl. 50, 46s
Year: 2006

Clinical implications of incidental venous thromboembolism in cancer patients
Source: Eur Respir J, 55 (2) 1901697; 10.1183/13993003.01697-2019
Year: 2020

Comparison of three clinical probability methods among patients with suspected pulmonary thromboembolism
Source: Annual Congress 2008 - Pulmonary venous thromboembolic disease
Year: 2008

Risk stratification of pulmonary embolism: clinical evaluation, biomarkers or both?
Source: Eur Respir J 2015; 46: 1551-1553
Year: 2015

Clinical usefulness of D-dimer in cancer patients with suspected pulmonary embolism
Source: Eur Respir J 2003; 22: Suppl. 45, 220s
Year: 2003

Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study
Source: Eur Respir J 2017; 49(1): 1600282; DOI: 10.1183/13993003.00282-2016
Year: 2017

Role of a clinical prediction score in a chronic thromboembolic pulmonary hypertension rule-out strategy
Source: Eur Respir J, 51 (4) 1702576; 10.1183/13993003.02576-2017
Year: 2018

Evolution of CT findings after anticoagulant treatment for acute pulmonary embolism in patients with and without an ultimate diagnosis of chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 58 (6) 2100699; 10.1183/13993003.00699-2021
Year: 2021

Earlier diagnosis and international registries may improve outcomes in pulmonary tumour thrombotic microangiopathy
Source: Eur Respir J 2016; 47: 690-691
Year: 2016

The evaluation of medication adherence in patients with pulmonary thromboembolism
Source: International Congress 2018 – Acute pulmonary embolism: from diagnosis to treatment
Year: 2018

Comparison of three clinical scoring methods in patients with pulmonary thromboembolism
Source: Annual Congress 2006 - Pulmonary embolism
Year: 2006

Interpreting risk reduction in clinical trials for pulmonary arterial hypertension
Source: Eur Respir Rev, 27 (148) 180020; 10.1183/16000617.0020-2018
Year: 2018

Is there hope of improving the prognosis of pulmonary tumour thrombotic microangiopathy?
Source: Eur Respir J 2016; 47: 688-690
Year: 2016

The clinical role of routine non-invasive parameters in the diagnostic work-up of patients with risk for pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models
Year: 2012

The comparison of three different clinical probability methods and the ECG score in patients with suspected venous thromboembolism
Source: Annual Congress 2007 - Venous thromboembolic disease
Year: 2007

Risks of pulmonary thromboembolism associated with ambulatory management of clinically proven deep vein thrombosis
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005

Computed tomography lung parenchymal descriptions in routine radiological reporting have diagnostic and prognostic utility in patients with idiopathic pulmonary arterial hypertension and pulmonary hypertension associated with lung disease
Source: ERJ Open Res, 8 (1) 00549-2021; 10.1183/23120541.00549-2021
Year: 2022

Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018